Live Breaking News & Updates on Biocity Biopharma

Stay updated with breaking news from Biocity biopharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Roche vet James Sabry departs—Chutes & Ladders

Roche vet James Sabry departs—Chutes & Ladders
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

Switzerland , Netherlands , Swiss , Dutch , Kevin-gorman , Kyle-gano , Neurocrine-biosciences , Ideaya-biosciences , Vered-bisker-leib , James-ahlers , Andrew-bellinger , Phil-nickson

Omega Therapeutics Appoints Kaan Certel, Ph.D., as Chief Business Officer

Omega Therapeutics Appoints Kaan Certel, Ph.D., as Chief Business Officer
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

Biocity-biopharma , Massachusetts-institute-of-technology , Koch-institute-for-integrative-cancer-research , University-of-iowa , Chief-business-officer , Global-head , Oncology-external-innovation , X-chem-pharmaceutical , Koch-institute , Integrative-cancer-research , Massachusetts-institute ,

BioCity Announces FDA Clearance of the Investigational New Drug Application for its First-In-Class Antibody Drug Conjugate Targeting Glypican 3

/PRNewswire/ BioCity Biopharma today announced that the U.S. Food and Drug Administration (FDA) has cleared the company s Investigational New Drug (IND). ....

Yong-jiang , Zhejiang , China , Shanghai , Biocity-adcs , Prnewswire-biocity-biopharma , Linkedin-biocity-biopharma , Biocity-biopharma , Drug-administration , City-biopharma , Investigational-new-drug , Yong-jiang-hei

Next-Gen PARP Inhibitor Shows Benefit in Breast Cancer Patients

Next-Gen PARP Inhibitor Shows Benefit in Breast Cancer Patients
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Oregon , United-states , Hong-kong , United-kingdom , Switzerland , Texas , Swiss , American , Haihe-biopharma , Biocity-biopharma , Calithera-biosciences , Terremoto-biosciences

BioCity announces the first patient dosed with its anti-TIM-3 mAb BC3402 in Combination with IMFINZI for the Treatment of Advanced Hepatocellular Carcinoma in a Phase Ib/II Trial

/PRNewswire/ BioCity Biopharma today announced dosing of the first patient in a Phase Ib/II clinical trial of its anti-TIM-3 monoclonal antibody (mAb). ....

Zhongshan , Anhui , China , Chinese , Biocity-biopharma , Jia-fan , Prnewswire-biocity-biopharma , Astrazeneca , Chinese-academy-of-sciences , City-biopharma , Zhongshan-hospital , Chinese-academy